Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan.
- Author:
Yuanzhi HE
1
;
Wei ZHANG
2
;
Tao GUO
2
;
Guoqing ZHANG
2
;
Wei QIN
1
;
Liu ZHANG
2
;
Caifen WANG
2
;
Weifeng ZHU
1
;
Ming YANG
1
;
Xiaoxiao HU
2
;
Vikramjeet SINGH
3
;
Li WU
2
;
Ruxandra GREF
3
;
Jiwen ZHANG
1
Author Information
- Publication Type:Journal Article
- Keywords: Azilsartan; Bioavailability; Mechanism; Molecular modeling; Nanoclusterization; Solubility; γ-Cyclodextrin metal-organic framework
- From: Acta Pharmaceutica Sinica B 2019;9(1):97-106
- CountryChina
- Language:English
- Abstract: Tremendous efforts have been devoted to the enhancement of drug solubility using nanotechnologies, but few of them are capable to produce drug particles with sizes less than a few nanometers. This challenge has been addressed here by using biocompatible versatile -cyclodextrin (-CD) metal-organic framework (CD-MOF) large molecular cages in which azilsartan (AZL) was successfully confined producing clusters in the nanometer range. This strategy allowed to improve the bioavailability of AZL in Sprague-Dawley rats by 9.7-fold after loading into CD-MOF. The apparent solubility of AZL/CD-MOF was enhanced by 340-fold when compared to the pure drug. Based on molecular modeling, a dual molecular mechanism of nanoclusterization and complexation of AZL inside the CD-MOF cages was proposed, which was confirmed by small angle X-ray scattering (SAXS) and synchrotron radiation-Fourier transform infrared spectroscopy (SR-FTIR) techniques. In a typical cage-like unit of CD-MOF, three molecules of AZL were included by the -CD pairs, whilst other three AZL molecules formed a nanocluster inside the 1.7 nm sized cavity surrounded by six -CDs. This research demonstrates a dual molecular mechanism of complexation and nanoclusterization in CD-MOF leading to significant improvement in the bioavailability of insoluble drugs.